CEVR
@TuftsCEVR
Followers
3K
Following
4K
Media
953
Statuses
4K
Center for the Evaluation of Value & Risk in Health (CEVR) at @TuftsMedicalCtr. Postings and RTs are not endorsements.
Boston, MA
Joined April 2012
RT @PeterNeumann11: The outlook for US payer coverage of specialty drugs in 2005. Register here for our webinar, Dec 4, 3-3:30 ET: https….
0
4
0
One week left to register for CEVR's webinar on payer coverage of specialty therapies in 2025!.
What is the outlook for US payer coverage of specialty therapies in 2025? Expect more utilization management on pricey therapies. For more insights, register for CEVR's December 4 webinar led by @jchambers241 here:.
0
0
0
What is the outlook for US payer coverage of specialty therapies in 2025? Expect more utilization management on pricey therapies. For more insights, register for CEVR's December 4 webinar led by @jchambers241 here:.
0
1
4
CEVR is now accepting nominations for the 7th annual "CEA Paper of the Year" award. New this year: a second award for best application of the CEA Registry. Submissions due Jan. 31, 2025. Papers must be published in 2024. Prize: $500. Details:
0
1
3
Authors: Katherine Clifford, @adelealexandr, Dan Enright, @PeterNeumann11, @jchambers241. @Health_Affairs.
0
0
0
Small molecules and biologics are eligible for #IRA price negotiation 9 vs 13 years after approval. New CEVR research shows small molecules give similar health benefits at lower cost than biologics. Should IRA be reformed to set equivalent timelines?.
healthaffairs.org
The Inflation Reduction Act of 2022 requires that Medicare negotiate a Maximum Fair Price for selected small-molecule drugs nine years after their Food and Drug Administration (FDA) approval and...
1
1
3
A cost-effective treatment for #Alzheimers would improve US population health and health equity. Read the new distributional CEA by CEVR and @genentech for data-driven insights on policies to further mitigate disparities.
jamanetwork.com
This economic evaluation estimates the health equity impact of a hypothetical disease-modifying treatment for early Alzheimer disease (AD) in the US and examines policies designed to mitigate health...
0
2
8
Last chance to register for our October 31 webinar on the importance of conducting non-drug value assessments!. Register here:
Drug value assessments are important, but economists shouldn't neglect assessment of health services and procedures. Hear perspectives from CEVR's @PeterNeumann11, @RxEconomics, and EBRI's @pfronstin during Oct. 31 public webinar. Register now:
0
0
0
Drug value assessments are important, but economists shouldn't neglect assessment of health services and procedures. Hear perspectives from CEVR's @PeterNeumann11, @RxEconomics, and EBRI's @pfronstin during Oct. 31 public webinar. Register now:
0
5
8
The full agenda for the 10/26 Tufts-CEVR / Duke Margolis event is now available. Visit the CEVR website for download and registration links: #CEA #heor #healthcare.
0
0
3
We are thrilled to announce that pioneering #CEA researcher Milton C. Weinstein has joined Panel 2 at the 10/26 Tufts-CEVR / Duke Margolis symposium. Register now!. In person: Webinar:
The 2nd panel at 10/26 Tufts-CEVR / Duke Margolis symposium will feature reflections on CEA from three luminaries: @AnkurFactorial, Marthe Gold, and Charles Phelps. Register now:. In Person: Webinar:
0
5
9
Despite high demand, many low + middle income countries lack capacity to conduct full HTA. Rapid "adaptive HTA" can bridge this gap - new @idsihealth / @CGDev guidelines by CEVR's Dan Ollendorf et al show how. Blog:
cgdev.org
Priority-setting in health is a critical function of all health systems, enabling countries to focus their spending on services that have the biggest impact on their citizens’ health. This works—for...
0
0
3
What does the future hold for CEA? Hear from experts @WrightCensored, @feralaes, @nlcrossnohere, and David Kim during Panel 5 at 10/26 Tufts-CEVR / Duke Margolis event. Register now:. In-person: Webinar:
0
4
4
We are pleased to announce that @brianreid, a nationally-recognized expert in prescription drug policy and communications, has joined CEVR as a Senior Fellow. Brian's work w/ CEVR to focus on drug policy, IRA impacts, PBM effects on cost/access. More at:
0
0
5
Join us in Las Vegas for #AMCPNexus 2024 for 2 educational sessions by @jchambers241 and @mollytoba's presentation of Fariel LaMountain's Platinum Ribbon-winning research on adalimumab product coverage. A full list of CEVR participation can be found here:
0
4
4
What is/will be the role of #CEA in public policy? Hear from @sarahkemond, @contirena1, @ProfLouGarrison, Steven Kymes, and @laprosser during Panel 4 at 10/26 Tufts-CEVR / Duke Margolis event. Register now:. In-Person: Webinar:
0
4
4
What does the future hold for the QALY - replacement or revision? Join CEVR for an online health policy seminar led by @ChrisSampson87, Sr. Principal Economist at @OHENews, to find out. Oct. 2 from 2-3 pm ET. Details and join link here:
0
0
4
Eager to learn about new #CEA methods from leading scientists? Join Anirban Basu, Darius Lakdawalla, Melanie Whittington, and Beth Woods for Panel 3 at 10/26 Tufts-CEVR / Duke Margolis Symposium. Register now:. In Person: Webinar:
The 2nd panel at 10/26 Tufts-CEVR / Duke Margolis symposium will feature reflections on CEA from three luminaries: @AnkurFactorial, Marthe Gold, and Charles Phelps. Register now:. In Person: Webinar:
0
2
5